Souris And NotChristoph M. Kosinski
List of bibliographic references
Number of relevant bibliographic references: 24.Ident. | Authors (with country if any) | Title |
---|---|---|
000488 | Benjamin Dehay [France] ; Erwan Bezard [France] | New Animal Models of Parkinson's Disease |
000731 | Erwan Bezard [France] ; Serge Przedborski [États-Unis] | A Tale on Animal Models of Parkinson's Disease |
000994 | Hans C. Scholle [Allemagne] ; H. A. Jinnah [États-Unis] ; Dirk Arnold [Allemagne] ; Frank H. W. Biedermann [Allemagne] ; Bernd Faenger [Allemagne] ; Roland Grassme [Allemagne] ; Ellen J. Hess [États-Unis] ; Nikolaus P. Schumann [Allemagne] | Kinematic and Electromyographic Tools for Characterizing Movement Disorders in Mice |
001146 | Thomas L. Shirley [États-Unis] ; Lekha M. Rao [États-Unis] ; Ellen J. Hess [États-Unis] ; H. A. Jinnah [États-Unis] | Paroxysmal Dyskinesias in Mice |
001204 | Mitchell F. Brin [États-Unis] ; Cynthia L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; Francis Lai [États-Unis] ; Markus Naumann [Allemagne] | Long-Term Treatment with Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay |
001510 | Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada] | Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle |
001589 | Nadia Stefanova [Autriche] ; Markus Reindl [Autriche] ; Manuela Neumann [Allemagne] ; Philipp J. Kahle [Allemagne] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Microglial Activation Mediates Neurodegeneration Related to Oligodendroglial α-Synucleinopathy : Implications for Multiple System Atrophy |
001614 | Anthony P. Nicholas [États-Unis] | Levodopa-induced hyperactivity in mice treated with 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
001650 | Nadia Stefanova [Autriche] ; Martin Köllensperger [Autriche] ; Monika Hainzer [Autriche] ; Angela Cenci [Suède] ; Werner Poewe [Autriche] ; Gregor Karl Wenning [Autriche] | High dose Levodopa therapy is not toxic in multiple system atrophy: Experimental evidence |
001D91 | Dirk Dressler [Allemagne] ; M. Lange [Allemagne] ; Hans Bigalke [Allemagne] | Mouse diaphragm assay for detection of antibodies against botulinum toxin type B |
001E82 | Jason D. Dapper [États-Unis] ; Monica J. Justice [États-Unis] | Defining the breakpoints of the Quakingviable mouse mutation reveals a duplication from a Parkin intron |
001F37 | Gwenaelle Fillon [Allemagne] ; Philipp J. Kahle [Allemagne] | Alpha-synuclein transgenic mice : Relevance to multiple system atrophy |
002011 | H. A. Jinnah [États-Unis] ; Ellen J. Hess [États-Unis] ; Mark S. Ledoux [États-Unis] ; Nutan Sharma [États-Unis] ; Mark G. Baxter [Royaume-Uni] ; Mahlon R. Delong [États-Unis] | Rodent models for dystonia research : Characteristics, evaluation, and utility |
002120 | Paul J. Lockhart [États-Unis] ; Casey A. O'Farrell [États-Unis] ; Matthew J. Farrer [États-Unis] | It's a double knock-out! The Quaking mouse is a spontaneous deletion of Parkin and Parkin co-regulated gene (PACRG) |
002491 | Ruth H. Walker [États-Unis] ; P. Shashidharan [États-Unis] | Developments in the molecular biology of DYT1 dystonia |
002A41 | Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice |
002B86 | L. C. Abbott [États-Unis] ; M. Bump [États-Unis] ; A. Brandl [États-Unis] ; S. De Laune [États-Unis] | Investigation of the role of the cerebellum in the myoclonic-like movement disorder exhibited by tottering mice |
002C09 | Rebecca J. Carter [Royaume-Uni] ; Mark J. Hunt [Royaume-Uni] ; A. Jennifer Morton [Royaume-Uni] | Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene |
002C43 | H. A. Jinnah [États-Unis] ; J. P. Sepkuty [États-Unis] ; T. Ho [États-Unis] ; S. Yitta [États-Unis] ; T. Drew [États-Unis] ; J. D. Rothstein [États-Unis] ; E. J. Hess [États-Unis] | Calcium channel agonists and dystonia in the mouse |
002D69 | F. Cardozo-Pelaez [États-Unis] ; SHIJIE SONG ; A. Parthasarathy ; C. Hazzi ; K. Naidu ; J. Sanchez-Ramos | Oxidative DNA damage in the aging mouse brain |
002E65 | E. Grünblatt [Israël] ; S. Mandel [Israël] ; T. Berkuzki [Israël] ; M. B. H. Youdim [Israël] | Apomorphine protects against MPTP-induced neurotoxicity in mice |
003130 | M. Jaber [États-Unis] ; S. Jones ; B. Giros ; M. G. Caron | The dopamine transporter : A crucial component regulating dopamine transmission |
003176 | E. S. Simon [États-Unis] | Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits |
003198 | G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine] | Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon |
This area was generated with Dilib version V0.6.23. |